A simple genetic screening test has the potential to stop almost a quarter of premature preventable deaths from common diseases including breast cancer, diabetes, and hypertension by identifying those most at risk, according to new research. The genetic warning signs would allow health authorities to offer vulnerable groups earlier investigation and treatment, according to the study published on Wednesday by Stanford University researchers and UK-based healthcare company Genomics.
The work highlights how vast databanks of personal genetic information are transforming scientists’ ability to spot features that make people prone to deadly conditions. Earlier interventions in such cases could improve public health and save money that would otherwise be spent on treating acute illnesses.
“We are excited about the potential of genomics in addressing the significant public health challenge of premature mortality,” said Jack W O’Sullivan, study co-author and cardiovascular medicine postdoctoral fellow at Stanford Medicine. “By leveraging genomics, we envision a future where patients can experience more personalised care.”
